Reasons for not being on a long-term oral anticoagulant strategy after discharge (n=95)
| Patient refusal | 2/95 (2.1) | ||
| Bleeding risk | 82/95 (86.3) | ||
| Previous haemorrhage | 54/82 (65.8) | ||
| Intracranial | 42/54 (77.8) | ||
| GI bleed | 5/54 (9.3) | ||
| ENT | 1/54 (1.9) | ||
| Respiratory tract | 2/54 (3.7) | ||
| Superficial/haematoma | 3/54 (5.6) | ||
| Genitourinary tract | 4/54 (7.4) | ||
| Chronic anaemia | 2/54 (3.7) | ||
| Trauma | 4/54 (7.4) | ||
| Other | 2/54 (3.7) | ||
| Never bleed but perceived as at increased risk of bleeding | 28/82 (34.1) | ||
| Unobservant or perceived as unobservant | 1/95 (1.1) | ||
| Uncertainty about patient’s ability to understand treatment* | 6/95 (6.3) | ||
| Others | 17/95 (17.8) | ||
| Chronic alcoholism or drug addiction | 0/17 (0.0) | ||
| Severe hepatic disease | 0/17 (0.0) | ||
| Specific contraindication to VKA | 0/17 (0.0) | ||
| Specific contraindication to NOAC | 1/17 (5.8) | ||
| Bedridden and cognitive deterioration | 16/17 (94.1) | ||
*Cognitive deterioration, low level of education, not French speaking.
ENT, ear, nose, throat; NOAC, new oral anticoagulant; VKA, vitamin K antagonist.